Voyager Therapeutics (VYGR) Tops Q1 EPS by 6c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.47), $0.06 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.17 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
• Barclays Downgrades Telenor ASA (TEL:NO) (TELNY) to Underweight
• Elisa Oyj (ELISA:FH) (ELMUF) PT Lowered to EUR40 at Barclays